MAMona M. A. Alharas

Mona M. A. Alharas

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mona M. A. Alharas has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Tailored Novel Azomethine Ligand and Its Cu(II) Complex for Improving Corrosion Resistance and Charge–Discharge Performance of Ni in Acidic Media

    by Hoda Abd El‐Shafy Shilkamy, Mehran Feizi‐Dehnayebi, Rafat M. El‐Khatib, Mona M. A. Alharas, Rawan Al‐Faze, Ahmed M. Abu‐Dief

    The ligand and its resulting CuL complex have been synthesized and meticulously characterized using a suite of spectroscopic and physicochemical techniques. These analyses reveal that the CuL complex exhibits an octahedral geometry, as confirmed by DFT calculations. These compounds not only are significant for their structural properties but also serve as potent and environmentally friendly corrosion inhibitors for nickel and its alloy systems. The efficacy of these inhibitors was evaluated in a 0.5‐M H2SO4 solution, simulating a harsh acidic environment. Electrochemical methods such as impedance spectroscopy and Tafel analysis were employed to scrutinize the performance of the L ligand, the CuL complex, and their combined effect on the corrosion process of nickel in the specified acidic medium. The study underscores the relationship between the corrosion rate of nickel and the presence or absence of these inhibitors. The addition of these substances significantly mitigates the corrosion process, showcasing their protective capabilities. Interestingly, the inhibitory properties of the L ligand and CuL complex are influenced by temperature variations. At elevated temperatures, particularly 55°C, the efficiency of inhibition is substantially enhanced, especially when the concentration of the L ligand reaches 1 × 10−3 M, as well CuL as additives, η = 98.5% and 99.7%. The enhancement of inhibitory efficacy as a function of temperature suggests that the additives undergo a chemisorption mechanism on the Ni surface within an acidic environment. This phenomenon is observed when these substances are introduced into the solution, leading to the formation of a protective layer that mitigates the corrosion process. Overall, the findings showed that increasing the temperature of a solution containing varying amounts of the CuL addition increases the inhibitory impact more than utilizing its ligand.


  • Design, Synthesis, Physico‐Chemical Characterization, Stability Determination, and Biomedical Applications of Some Novel Tetra‐Dentate Imine Metal Chelates Supported by Theoretical Approaches: Bridging Coordination Chemistry and Life Sciences

    by Inam Omar, Mona M. A. Alharas, Mehran Feizi‐Dehnayebi, Sultan K. Alharbi, Hala M. Abo‐Dief, Hamza A. Qasem, Rafat M. El‐Khatib, Ahmed M. Abu‐Dief

    The synthesis of 4‐Bromo‐2‐({2‐[(5‐bromo‐2‐hydroxy‐benzylidene)‐amino]‐5‐nitro‐phenylimino}‐methyl)‐phenol (BSNP ligand), a straightforward, highly adjustable, and efficient BSNP ligand, was demonstrated. Four novel BSNP ligand coordinating compounds were created. The structures of these compounds were clarified by a variety of spectroscopic and analytical techniques, such as elemental analysis (CHN), spectroscopy (IR, NMR, mass spectrometry), conductivity, magnetic susceptibility, UV–Vis spectrum studies, and theoretical investigations. Additional analysis of the compounds showed that they were surrounded by an octahedral‐coordinating environment. With conductance values ranging from 0.9.60 to 11.87 Ω−1 cm2 mol−1, molar conductance values showed that the Fe (III), Zn (II), Cu (II), and Ru (III) complexes are non‐electrolytes in fresh DMSO solutions, with the exception of the BSNPRu complex, which is mono electrolyte. According to IR spectra, the ligand uses the (N and O) donor sites from the (C=N and C‐O) groups in the ligand moiety to coordinate through the metal ions in a tetra‐dentate form. A 1:1 (metal:ligand) molar ratio was proposed by Job's approach based on analytical data from solution complexation. According to the stability constant (Kf) values, the complexes' stability order was found to be BSNPFe > BSNPRu > BSNPCu > BSNPZn. The pH profile showed that the complexes under study are stable throughout a broad pH range, usually between pH = 4 and pH = 10. The complexes' geometric structures and ligand coordination capabilities were inferred with the use of magnetic and electronic spectrum studies. To gain deeper insights into the reactivity and potential biological activity of the synthesized metal complexes, DFT calculations were performed. The computational analysis was carried out using the DFT/B3LYP/6‐311g (d,p)/LANL2DZ level in the gas phase in order to explore the active sites and quantum chemical reactivity of the compounds. Building on the encouraging results from our in‐vitro analyses, which demonstrated notable antimicrobial, antifungal, and anticancer properties of the synthesized metal complexes, molecular docking simulations were subsequently performed to further substantiate these promising biological activities. The anti‐pathogenic activity of the generated materials was experimentally verified against a subset of gram (+) and gram (−) bacteria as well as some fungi using the agar well diffusion method. Additionally, the BSPN ligand's and its metal compounds' cytotoxic action on liver cells, breast, and colon cancers was investigated. Furthermore, the examined compounds' ability to suppress the DPPH radical was examined. Additionally, simulations of molecular landing were performed to ascertain how the produced compounds attached to the specific protein binding sites. Some novel metal chelates incorporating 4‐Bromo‐2‐({2‐[(5‐bromo‐2‐hydroxy‐benzylidene)‐amino]‐5‐nitro‐phenylimino}‐methyl)‐phenol ligand were synthesized and their structures were elucidated by different physico‐chemical, analytical techniques, and computational. Moreover, all the new investigated metal chelates were tested in vitro against selected microbial strains and cancer cell lines as well as free radicals. Furthermore, biomedical applications of the investigated compounds were confirmed by docking studies.


  • Selective Novel Metal‐Coordinated Biomedical Agents Encompassing Tetradentate Salen Ligand: Structural Elucidation, DFT Calculation, Cytotoxic, and Antioxidant Activities Supported by Molecular Docking Approach

    by Khalaf Al‐Ghamdi, Mona M. A. Alharas, Samir A. Abdel‐Latif, Dalal Alhashmialameer, Eida S. Al‐Farraj, Manal A. Almalki, Rafat M. El‐Khatib, Ahmed M. Abu‐Dief

    Several physicochemical and analytical methods were employed to elucidate the structural analysis of some novel complexes derived from the {3,4‐bis‐[(3‐ethoxy‐2‐hydroxy‐benzylidene)‐amino]‐phenyl}‐phenyl‐methanone (ESAB ligand). Decomposition point determination, elemental analysis (CHN), spectroscopy (IR, NMR, and mass spectrometry), conductivity, magnetic susceptibility, UV–Vis spectrum study, and theoretical investigations were among these methods. With conductance values ranging from 7.5 to 15.12 Ω −1 cm 2 mol −1 , molar conductance values showed that the Zn (II), Cu (II), and Ru (III) complexes are nonelectrolytes in fresh DMSO solutions, with the exception of the ESABRu complex, which is a monoelectrolyte. According to IR spectra, the ligand uses the (N & O) donor sites from the (C=N & C‐O) groups in the ligand moiety to coordinate through the metal ions in a tetradentate form. A 1:1 (metal:ligand) molar ratio was proposed by Job's approach based on analytical data from solution complexation. According to the stability constant ( K f ) values, the complexes' stability order was found to be ESABRu > ESABCu > ESABZn. The pH profile showed that the complexes under study are stable throughout a broad pH range, usually between pH = 4 and pH = 10. The complexes' geometric structures and ligand coordination capabilities were inferred with the use of magnetic and electronic spectrum studies. The DFT method uses quantum chemical simulations to evaluate the electronic structures of the ligand under investigation and its complexes. The unbound ligand's B3LYP level, B3LYP/6/311G* degree, and the complexes' B3LYP/6/311G**/LANL2DZ functional categories were employed in the computations of the density function concept (DFT). The findings revealed the consistency between the experimental and DFT computations. Natural bond orbital (NBO) analysis was used to investigate bond strength between molecules' charge exchange, hyperconjugative connections, and molecular equilibrium. By computing the hyperpolarizability (β) and molecular polarizability (α) parameters, the ensuing nonlinear optical properties were investigated, leading to a number of surprising optical properties for the produced compounds. The antipathogenic activity of the generated materials was experimentally verified against a subset of gram (+) and gram (−) bacteria as well as some fungi using the agar well diffusion method. Additionally, hepatic cellular carcinomas, cells from colon and breast cancer, were utilized to test the cytotoxic activity of the ESAB ligand and its metal chelates. Furthermore, the examined compounds' ability to suppress the DPPH radical was examined. Additionally, simulations of molecular docking were performed to ascertain how the produced compounds attached to the specific protein binding sites.